--- title: "12 Health Care Stocks Moving In Thursday's After-Market Session" type: "News" locale: "en" url: "https://longbridge.com/en/news/295848412.md" description: "During Thursday's after-market session, several healthcare stocks experienced significant volatility driven by Q2 earnings reports. Gainers included Akanda (+109.4%), Capricor Therapeutics (+63.18%), and MDxHealth (+33.13%). Conversely, losers featured Cibus (-15.8%), Sensus Healthcare (-15.51%), and ARS Pharmaceuticals (-14.27%). Market caps ranged from $2.9 million to $2.5 billion." datetime: "2026-08-13T21:06:05.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/295848412.md) - [en](https://longbridge.com/en/news/295848412.md) - [zh-HK](https://longbridge.com/zh-HK/news/295848412.md) --- # 12 Health Care Stocks Moving In Thursday's After-Market Session ### Gainers - **Akanda** (NASDAQ:AKAN) stock rose 109.4% to $10.49 during Thursday's after-market session. The company's market cap stands at $2.9 million. - **Capricor Therapeutics** (NASDAQ:CAPR) stock moved upwards by 63.18% to $6.87. The company's market cap stands at $242.6 million. As per the news, the Q2 earnings report came out today. - **MDxHealth** (NASDAQ:MDXH) shares moved upwards by 33.13% to $0.62. The market value of their outstanding shares is at $24.1 million. The company's, Q2 earnings came out today. - **Dare Bioscience** (NASDAQ:DARE) shares increased by 21.89% to $1.67. The company's market cap stands at $21.5 million. As per the press release, Q2 earnings came out today. - **Eton Pharmaceuticals** (NASDAQ:ETON) shares moved upwards by 19.24% to $48.65. The company's market cap stands at $1.1 billion. The company's, Q2 earnings came out today. - **HeartFlow** (NASDAQ:HTFL) stock increased by 15.47% to $35.81. The market value of their outstanding shares is at $2.5 billion. As per the press release, Q2 earnings came out today. ### Losers - **Cibus** (NASDAQ:CBUS) stock decreased by 15.8% to $1.6 during Thursday's after-market session. The market value of their outstanding shares is at $144.2 million. As per the news, the Q2 earnings report came out today. - **Sensus Healthcare** (NASDAQ:SRTS) shares declined by 15.51% to $2.67. The market value of their outstanding shares is at $51.5 million. As per the press release, Q2 earnings came out today. - **ARS Pharmaceuticals** (NASDAQ:SPRY) stock fell 14.27% to $5.23. The market value of their outstanding shares is at $600.7 million. The company's, Q2 earnings came out today. - **BioXcel Therapeutics** (NASDAQ:BTAI) shares declined by 12.39% to $0.99. The company's market cap stands at $32.7 million. - **Zentalis Pharmaceuticals** (NASDAQ:ZNTL) stock fell 10.85% to $3.7. The market value of their outstanding shares is at $307.4 million. - **BeyondSpring** (NASDAQ:BYSI) shares declined by 10.72% to $0.89. The company's market cap stands at $30.5 million. **See Also:** www.benzinga.com/money/best-healthcare-stocks/ This article was generated by Benzinga's automated content engine and reviewed by an editor. ### Related Stocks - [MDXH.US](https://longbridge.com/en/quote/MDXH.US.md) - [CAPR.US](https://longbridge.com/en/quote/CAPR.US.md) - [CBUS.US](https://longbridge.com/en/quote/CBUS.US.md) - [AKAN.US](https://longbridge.com/en/quote/AKAN.US.md) - [SPRY.US](https://longbridge.com/en/quote/SPRY.US.md) - [SRTS.US](https://longbridge.com/en/quote/SRTS.US.md) - [DARE.US](https://longbridge.com/en/quote/DARE.US.md) - [ETON.US](https://longbridge.com/en/quote/ETON.US.md) - [HTFL.US](https://longbridge.com/en/quote/HTFL.US.md) - [BTAI.US](https://longbridge.com/en/quote/BTAI.US.md) - [ZNTL.US](https://longbridge.com/en/quote/ZNTL.US.md) - [BYSI.US](https://longbridge.com/en/quote/BYSI.US.md) ## Related News & Research - [Analyst Sees Operational Inflection and Strengthening Demand Supporting Buy Rating on Sensus Healthcare](https://longbridge.com/en/news/296006310.md) - [Hennion & Walsh Asset Management Inc. Acquires Shares of 175,614 ARS Pharmaceuticals, Inc. $SPRY](https://longbridge.com/en/news/295770946.md) - [Capricor Therapeutics (CAPR) Could Be 89% Undervalued Following Deramiocel And Loss Concerns](https://longbridge.com/en/news/296098763.md) - [CAPR Stock News: Capricor Therapeutics Sued for Securities Fraud over Alleged Misrepresentations and Corresponding 64% Stock Drop](https://longbridge.com/en/news/296212809.md) - [Key facts: Capricor (NASDAQ:CAPR) Q2 loss $40.7M; HOPE-3 breach suit](https://longbridge.com/en/news/295895316.md)